© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Baron Opportunity Fund Retail Shs (BIOPX) shows an Average True Range (ATR) of N/A and an Enterprise Value of N/A. Its average trading volume over the past 3 months is N/A, indicating liquidity. These fundamental metrics provide insight into BIOPX's underlying financial health and market activity.
| ATR | N/A |
| Enterprise Value | - |
| Avg Vol (3 Months) | - |
| Avg Vol (10 Days) | - |
Baron Opportunity Fund Retail Shs (BIOPX) technical indicators as of September 12, 2026: the SMA 20 is N/A, SMA 50 at N/A, and SMA 200 at N/A. The RSI 14 value is N/A, suggesting its current momentum. These technical analysis signals help assess BIOPX's price trends and potential future movements.
| SMA 20 | N/A |
| SMA 50 | N/A |
| SMA 200 | N/A |
| RSI 14 | N/A |
Baron Opportunity Fund Retail Shs (BIOPX) stock performance overview as of September 12, 2026: The 52-week high is $63.99 (currently N/A below), and the 52-week low is $47.46 (currently N/A above). Over the past year, BIOPX's performance is N/A, compared to the S&P 500's 0.26% change.
| 52-Week High | 63.99 |
| 52-Week High Chg | - |
| 52-Week Low | 47.46 |
| 52-Week Low Chg | - |
| S&P 500 52-Week Chg | 0.26% |
According to market data, Baron Opportunity Fund Retail Shs (BIOPX) stock's recent performance metrics show that over the last month, BIOPX is N/A, with a Year-to-Date (YTD) performance of N/A. Over the past year, the stock has seen a N/A change. These figures summarize BIOPX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 62.47 | 62.98 | 63.99 | 63.99 | 63.99 | 63.99 |
| Low | 60.87 | 60.6 | 54.83 | 47.46 | 47.46 | 47.46 |
| Performance | - | - | - | - | - | - |
According to current financial data, BIOPX stock's P/E (TTM) ratio is N/A, which compares to the S&P 500's P/E of 32.59. The sector median P/E is 7.19. Key valuation ratios for BIOPX, including P/S (N/A), P/B (N/A), and P/FCF (N/A), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | BIOPX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | N/A | 7.19 | 929.4 | 32.59 |
| P/S (TTM) | N/A | 1.92 | -514204.76 | 5.98 |
| P/B (TTM) | N/A | N/A | -162161.01 | 5.59 |
| P/FCF (TTM) | N/A | N/A | -6306.38 | 28.73 |